thyroglobulin tumor marker
Selected indexed studies
- THYROGLOBULIN AS A TUMOR MARKER IN DIFFERENTIATED THYROID CANCER - CLINICAL CONSIDERATIONS. (Acta Clin Croat, 2018) [PMID:31168186]
- [Thyroglobulin - An important tumor marker and laboratory challenge]. (Dtsch Med Wochenschr, 2026) [PMID:41558494]
- Anti-Thyroglobulin Antibodies as a Surrogate Tumor Marker for the Follow-Up of the Differentiated Thyroid Carcinoma: Clinical Implications and Pitfalls. (Balkan Med J, 2026) [PMID:42057486]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- THYROGLOBULIN AS A TUMOR MARKER IN DIFFERENTIATED THYROID CANCER - CLINICAL CONSIDERATIONS. (2018) pubmed
- [Thyroglobulin - An important tumor marker and laboratory challenge]. (2026) pubmed
- Anti-Thyroglobulin Antibodies as a Surrogate Tumor Marker for the Follow-Up of the Differentiated Thyroid Carcinoma: Clinical Implications and Pitfalls. (2026) pubmed
- Hürthle cell carcinoma. (2001) pubmed
- Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. (2004) pubmed
- Thyroglobulin-to-tumor volume ratio combined with ultrasound features for diagnosing thyroid follicular neoplasms. (2025) pubmed
- Serum biomarkers for thyroid cancer. (2020) pubmed
- Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma. (1995) pubmed
- Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications. (2010) pubmed
- Relationship between amino acid transporter activity and radioactive iodine therapy efficacy in differentiated thyroid cancer. (2025) pubmed